Cantel Medical (CMD)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
80.37 -0.96 (-1.18%) 06/01/21 [NYSE]
N/A x N/A N/A x N/A
Post-market 80.37 unch (unch) -
for Tue, Jun 1st, 2021
Fiscal Year End Date: 07/31
(Values in U.S. thousands)
07-2020 | 07-2019 | 07-2018 | 07-2017 | 07-2016 | |
Sales | 1,016,048 | 918,155 | 871,922 | 770,157 | 664,755 |
Cost of Goods | 580,075 | 490,701 | 457,951 | 402,997 | 355,569 |
Gross Profit | 435,973 | 427,454 | 413,971 | 367,160 | 309,186 |
Operating Expenses | 387,741 | 344,636 | 293,258 | 257,747 | 212,504 |
Operating Income | 48,307 | 83,519 | 121,664 | 110,410 | 97,251 |
Interest Expense | 41,355 | 9,505 | 5,289 | 4,303 | 3,320 |
Other Income | 0 | 1,305 | 1,138 | 126 | 0 |
Pre-tax Income | 6,952 | 75,319 | 117,513 | 106,233 | 93,931 |
Income Tax | -6,756 | 20,277 | 26,472 | 34,855 | 33,978 |
Net Income Continuous | 13,708 | 55,042 | 91,041 | 71,378 | 59,953 |
Net Income | $13,708 | $55,042 | $91,041 | $71,378 | $59,953 |
EPS Basic Total Ops | 0.32 | 1.32 | 2.18 | 1.71 | 1.44 |
EPS Basic Continuous Ops | 0.32 | 1.32 | 2.19 | 1.72 | 1.45 |
EPS Diluted Total Ops | 0.32 | 1.32 | 2.18 | 1.71 | 1.44 |
EPS Diluted Continuous Ops | 0.32 | 1.32 | 2.19 | 1.72 | 1.45 |
EPS Diluted Before Non-Recurring Items | 1.65 | 2.37 | 2.51 | 2.08 | 1.75 |
EBITDA(a) | $122,651 | $125,878 | $156,494 | $143,862 | $122,335 |